High-Content Flow Cytometry and Temporal Data Analysis for Defining a Cellular Signature of Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 6, 2007, Pages 691-700

  Brinkman, Ryan Remy ^a   Gasparetto, Maura ^a   Lee, Shang Jung Jessica ^a   Ribickas, Albert J ^b   Perkins, Janelle ^b   Janssen, William ^b   Smiley, Renee ^b   Smith, Clay ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Bioinformatics; Graft versus host disease; High content flow cytometry

Indexed keywords

BUSULFAN; CARMUSTINE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BIOINFORMATICS; BLOOD SAMPLING; CLINICAL ARTICLE; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; EFFECTOR CELL; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE SUBPOPULATION; PANCREAS ISLET BETA CELL; PHENOTYPE; PREDICTION; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; VALIDATION PROCESS; WHOLE BODY RADIATION;

ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PREDICTIVE VALUE OF TESTS; TIME;

EID: 34248652720     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.02.002     Document Type: Article

References (43)

1. Chao N.J. Graft-versus-host disease: the viewpoint from the donor T cell. Biol Blood Marrow Transplant 3 (1997) 1-10
2. Couriel D., Caldera H., Champlin R., and Komanduri K. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 101 (2004) 1936-1946
3. Gilliam A.C. Update on graft versus host disease. Prog Dermatol 123 (2004) 251-257
4. Goker H., Haznedaroglu I.C., and Chao N.J. Acute graft-vs-host disease: pathobiology and management. Exp Hematol 29 (2001) 259-277
5. Martin P.J., Schoch G., Fisher L., et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 76 (1990) 1464-1472
6. Reddy P. Pathophysiology of acute graft-versus-host disease. Hematol. Oncol 21 (2003) 149-161
7. Vakkila J., Thomson A.W., Hovi L., Vettenranta K., and Saarinen-Pihkala U.M. Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease. Bone Marrow Transplant 35 (2005) 501-507
8. Chan G.W., Gorgun G., Miller K.B., and Foss F.M. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biol Blood Marrow Transplant 9 (2003) 170-176
9. Haraguchi K., Takahashi T., Matsumoto A., et al. Host-residual invariant NK T cells attenuate graft-versus-host immunity. J Immunol 175 (2005) 1320-1328
10. Nakamura A., Kobayashi E., and Takai T. Exacerbated graft-versus-host disease in Pirb-/- mice. Nat Immunol 5 (2004) 623-629
11. Lo J.W., Leung A.Y., Huang X.R., et al. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients. Bone Marrow Transplant 30 (2002) 375-380
12. Margalit O., Somech R., Amariglio N., and Rechavi G. Microarray-based gene expression profiling of hematologic malignancies: basic concepts and clinical applications. Blood Rev 19 (2005) 223-234
13. Akilesh S., Shaffer D.J., and Roopenian D. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. Genome Res 13 (2003) 1719-1727
14. Ichiba T., Teshima T., Kuick R., et al. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood 102 (2003) 763-771
15. Srour E.F., and Yoder M.C. Flow cytometric analysis of hematopoietic development. Methods Mol Med 105 (2005) 65-80
16. Dunphy C.H. Applications of flow cytometry and immunohistochemistry to diagnostic hematopathology. Arch Pathol Lab Med 128 (2004) 1004-1022
17. Goolsby C. A look at where we came from and where we are going. Cytometry 58A (2004) 53-54
18. Owen R.G., and Rawstron A.C. Minimal residual disease monitoring in multiple myeloma: flow cytometry is the method of choice. Br J Haematol 128 (2005) 732-733
19. Gasparetto M., Gentry T., Sebti S., et al. Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening. J Immunol Methods 292 (2004) 59-71
20. Edwards B.S., Oprea T., Prossnitz E.R., and Sklar L.A. Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol 8 (2004) 392-398
21. Bar-Joseph Z., Gerber G., Simon I., Gifford D.K., and Jaakkola T.S. Comparing the continuous representation of time-series expression profiles to identify differentially expressed genes. Proc Natl Acad Sci USA 100 (2003) 10146-10151
22. Bar-Joseph Z., Gerber G.K., Gifford D.K., Jaakkola T.S., and Simon I. Continuous representations of time-series gene expression data. J Comput Biol 10 (2003) 341-356
23. De Hoon M.J., Imoto S., and Miyano S. Statistical analysis of a small set of time-ordered gene expression data using linear splines. Bioinformatics (Oxford, England) 18 (2002) 1477-1485
24. Irizarry R.A., Tankersley C., Frank R., and Flanders S. Assessing homeostasis through circadian patterns. Biometrics 57 (2001) 1228-1237
25. James G., and Hastie T. Functional linear discriminant analysis for irregularly sampled curves. J R Stat Soc B 63 (2001) 533-550
26. James G., and Sugar C. Clustering for sparsely sampled functional data. J Am Stat Assoc 98 (2003) 397-408
27. Luan Y., and Li H. Clustering of time-course gene expression data using a mixed-effects model with B-splines. Bioinformatics (Oxford, England) 19 (2003) 474-482
28. Rice J.A., and Wu C.O. Nonparametric mixed effects models for unequally sampled noisy curves. Biometrics 57 (2001) 253-259
29. Storey J.D., Xiao W., Leek J.T., Tompkins R.G., and Davis R.W. Significance analysis of time course microarray experiments. Proc Natl Acad Sci USA 102 (2005) 12837-12842
30. Friedman J.H., and Silverman B.W. Flexible parsimonious smoothing and additive modeling (with discussion). Technometrics 31 (1989) 3-39
31. Gratwohl A., Hermans J., Apperley J., et al. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation. Blood 86 (1995) 813-818
32. Cohen J.L., and Boyer O. The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease. Curr Opin Immunol 18 (2006) 580-585
33. Nguyen V.H., Zeiser R., and Negrin R.S. Role of naturally arising regulatory T cells in hematopoietic cell transplantation. Biol Blood Marrow Transplant 12 (2006) 995-1009
34. Boeckh M., Fries B., and Nichols W.G. Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation. Pediatr Transplant 8 Suppl 5 (2004) 19-27
35. Nascimbeni M., Shin E.C., Chiriboga L., Kleiner D.E., and Rehermann B. Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. Blood 104 (2004) 478-486
36. Ortolani C., Forti E., Radin E., Cibin R., and Cossarizza A. Cytofluorimetric identification of two populations of double positive (CD4+,CD8+) T lymphocytes in human peripheral blood. Biochem Biophys Res Commun 191 (1993) 601-609
37. Tonutti E., Sala P., Feruglio C., Yin Z., and Colombatti A. Phenotypic heterogeneity of persistent expansions of CD4+ CD8+ T cells. Clin Immunol Immunopathol 73 (1994) 312-320
38. Weiss L., Roux A., Garcia S., et al. Persistent expansion, in a human immunodeficiency virus-infected person, of V beta-restricted CD4+CD8+ T lymphocytes that express cytotoxicity-associated molecules and are committed to produce interferon-gamma and tumor necrosis factor-alpha. J Infect Dis 178 (1998) 1158-1162
39. Jimenez E., Sacedon R., Vicente A., Hernandez-Lopez C., Zapata A.G., and Varas A. Rat peripheral CD4+CD8+ T lymphocytes are partially immunocompetent thymus-derived cells that undergo post-thymic maturation to become functionally mature CD4+ T lymphocytes. J Immunol 168 (2002) 5005-5013
40. Pahar B., Lackner A.A., and Veazey R.S. Intestinal double-positive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines. Eur J Immunol 36 (2006) 583-592
41. Szczepanik M., Bryniarski K., Tutaj M., et al. Epicutaneous immunization induces alphabeta T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta. Immunology 115 (2005) 42-54
42. dimCD8+T cells in peripheral blood. Cytometry B Clin Cytom 66 (2005) 10-17
43. Chen B.J., Deoliveira D., Cui X., et al. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood (2006) [Epub ahead of schedule].